Saniona
14.00 SEK
-0.21 %
Less than 1K followers
SANION
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Saniona
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.2 | 313.4 | 334.7 | 9.8 | 9.3 | 410.7 | 4.6 | 434.4 |
| EBITDA | -16.9 | 292.4 | 249.6 | -14.6 | -24.4 | 361.6 | -44.9 | 277.8 |
| EBIT | -18.9 | 290.4 | 241.9 | -16.5 | -25.9 | 359.9 | -46.5 | 271.0 |
| EBIT-% | -260.5 % | 92.7 % | 72.3 % | -167.9 % | -279.5 % | 87.6 % | -1,016.1 % | 62.4 % |
| Profit before taxes | -32.5 | 272.6 | 207.0 | 17.5 | -25.2 | 358.3 | -44.7 | 306.0 |
| Net income | -29.5 | 247.1 | 188.7 | 19.0 | -22.2 | 329.6 | -41.7 | 284.7 |